查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1576943

排便管理系统 - 市场考察，竞争情形，市场预测(2030年)

Bowel Management Systems - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

2023年全球排便管理系统市场规模为14.2亿美元，预计2030年将达到17.8亿美元，复合年增长率预计为3.98%。由于包括多发性硬化症在内的神经系统疾病的盛行率不断增加、产品开发活动的增加以及脊髓损伤病例的增加，该市场正在迅速扩大，预计在2024 年至2030 年的预测期内将加速整体成长。

排便管理系统的市场动态

根据世界卫生组织 (WHO) (2024) 的数据，2021 年全球有 1540 万人患有脊髓损伤。大多数脊髓损伤是由跌倒或暴力行为等创伤造成的，并且是可以预防的。

根据世界卫生组织 (2023) 数据，据报导全球有超过 180 万人受到多发性硬化症 (MS) 的影响。多发性硬化症影响多种功能，包括认知、情绪、运动、感觉和视觉功能。当免疫系统错误地攻击大脑和脊髓时就会发生这种情况。

脊髓损伤和多发性硬化症都会促使严重的肠道功能障碍，因此肠道管理系统在脊髓损伤和多发性硬化症患者的照护中发挥重要作用。对于脊髓损伤患者，肠道管理系统可以帮助鼓励规律排便，预防大便失禁等併发症，并改善整体生活品质。同样，多发性硬化症患者常因神经病变而难以控制肠道。实施有效的肠道管理系统可以更好地调节肠道功能，最大限度地减少不适，并促进受这些疾病影响的人的独立性。

市场主要参与者增加产品开发活动（例如产品发布）也有助于扩大市场收入占有率。例如，2024 年 2 月，康乐保推出了 Peristeen® Light，这是一种新型经肛门冲洗装置，旨在帮助患有肠道功能障碍和渗漏的患者。

因此，上述因素共同推动了整个肠道管理系统市场的成长。

然而，感染、皮肤刺激、肠道穿孔等副作用以及替代选择的可用性可能会对肠道管理系统市场的成长带来课题。

排便管理系统市场区隔分析

在肠道管理系统市场的产品类型领域，神经调节设备子类别预计将在 2023 年占据重要的收入占有率。这是由于神经调节装置的广泛使用及其提高其实用性和有效性的能力。

肠道管理系统的神经调节装置利用电刺激来调节肠道功能，为肠道功能障碍患者提供非侵入性解决方案。这些设备通常具有可调节的刺激设置，可以根据患者的独特需求进行个人化治疗。它们通常包括远端控製或基于应用程式的介面，以便于使用和监控。

在临床应用中，神经调节装置可有效管理大便失禁和便秘等病症，特别是对于患有影响肠道控制的神经系统疾病或创伤的患者。透过刺激骶神经，这些装置增加肠道蠕动，减少手动干预的需要，并改善整体肠道功能，从而显着改善患者的生活品质。

因此，神经调节设备的广泛使用和各种功能肯定会提高性能和易用性，从而对 2024-2030 年预测期内整个肠道管理系统市场的增长产生重大影响。

北美预计将主导整个肠道管理系统市场。

在所有地区中，北美预计将在 2023 年主导肠道管理系统市场，并在预测期内保持这一水平。帕金森氏症负担的增加、监管批准的增加以及成熟的医疗基础设施的存在是推动 2024-2030 年预测期内北美肠道管理系统市场成长的关键因素。

本报告提供全球排便管理系统市场相关调查分析，提供各地区市场规模与预测，过去3年的产品/技术开发，市场主要企业，未来的机会等资讯。

目录

第1章 排便管理系统市场报告的简介

第2章 排便管理系统市场摘要整理

  • 市场概要

第3章 竞争情形

第4章 法规分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 排便管理系统市场主要原因的分析

  • 排便管理系统市场促进因素
  • 排便管理系统市场阻碍因素与课题
  • 排便管理系统市场机会

第6章 排便管理系统市场波特的五力分析

第7章 排便管理系统市场评估

  • 各产品类型
    • 设备
    • 配件
  • 各患者类型
    • 成人
    • 儿童
  • 各终端用户
    • 医院
    • 门诊病人手术中心
    • 居家照护
  • 地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 排便管理系统市场企业与产品的简介

  • Coloplast Pty Ltd
  • Medtronic
  • ConvaTec Inc.
  • Hollister Incorporated
  • B. Braun Melsungen AG
  • 3M
  • Cardinal Health.
  • BD
  • Dentsply Sirona
  • Norgine
  • Attends Healthcare Products, Inc.
  • Teleflex Incorporated
  • Laborie
  • Consure Medical.
  • Axonics, Inc.
  • Renew Medical Inc

第9章 KOL的见解

第10章 计划的方法

第11章 关于DelveInsight

第12章 免责声明，咨询方式

Product Code: DIMDCL0318

Bowel Management Systems Market by Product Type (Devices [Irrigation Systems, Nerve Modulation Devices, and Others], and Accessories), Patient Type (Adult and Pediatrics), End-User (Hospitals, Ambulatory Surgical Centres, and Homecare), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing prevalence of neurological disorders and growing product developmental activities worldwide

The bowel management systems market was valued at USD 1.42 billion in 2023, growing at a CAGR of 3.98% during the forecast period from 2024 to 2030, in order to reach USD 1.78 billion by 2030. The bowel management systems market is expanding rapidly due to the increasing prevalence of neurological disorders including multiple sclerosis, growing product developmental activities, increasing instances of spinal cord injuries, and others that are expected to escalate the overall growth of the bowel management systems market during the forecast period from 2024 to 2030.

Bowel Management Systems Market Dynamics:

According to the World Health Organization (WHO) (2024) in 2021, 15.4 million people were living with spinal cord injuries globally. Most cases of spinal cord injury result from trauma, including falls, or acts of violence, and are therefore preventable.

As per data from the WHO (2023), it was reported that over 1.8 million people worldwide are affected by Multiple sclerosis (MS). It impacts various functions including cognitive, emotional, motor, sensory, and visual abilities. It occurs when the immune system mistakenly attacks the brain and spinal cord.

Bowel management systems play a crucial role in the care of individuals with spinal cord injuries and multiple sclerosis, as both conditions can lead to significant bowel dysfunction. For those with spinal cord injuries, bowel management systems help facilitate regular bowel movements and prevent complications such as fecal incontinence, enhancing overall quality of life. Similarly, patients with multiple sclerosis often experience challenges in bowel control due to neurological impairments. Implementing effective bowel management systems allows for better regulation of bowel function, minimizing discomfort and promoting independence for individuals affected by these conditions.

Rising product developmental activities such as product launches by the market key player are also contributing in increasing revenue shares for the same. For example, in February 2024, Coloplast launched Peristeen(R) Light, a new transanal irrigation device designed to assist individuals with bowel disorders, specifically those dealing with defecation issues or stool leakage.

Therefore, the factors stated above collectively will drive the overall bowel management systems market growth.

However, side-effects such as infections, skin irritation, and bowel perforation, among others, availability of alternative options, and others may prove to be challenging factors for bowel management systems market growth.

Bowel Management Systems Market Segment Analysis:

Bowel Management Systems Market by Product Type (Devices [Irrigation Systems, Nerve Modulation Devices, and Others], and Accessories), Patient Type (Adult and Pediatrics), End-User (Hospitals, Ambulatory Surgical Centres, and Homecare), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the bowel management systems market, the nerve modulation devices sub-category is expected to have a significant revenue share in the year 2023. This is because of the widespread uses and features of nerve modulation devices that enhance their utility and effectiveness.

Nerve modulation devices for bowel management systems utilize electrical stimulation to regulate bowel function, offering a non-invasive solution for individuals experiencing bowel dysfunction. These devices typically feature adjustable stimulation settings, allowing for personalized treatment tailored to the patient's specific needs. They often include remote control or app-based interfaces for ease of use and monitoring.

In clinical applications, nerve modulation devices are effective in managing conditions such as fecal incontinence and constipation, particularly in patients with neurological disorders or injuries affecting bowel control. By stimulating the sacral nerves, these devices can enhance bowel motility, reduce the need for manual interventions, and improve overall bowel function, thereby significantly enhancing patients' quality of life.

Therefore the widespread uses and various features of nerve modulation devices enhance performance and usability, solidifying the significant impact on the growth of the overall bowel management systems market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall bowel management systems market:

Among all the regions, North America is expected to dominate the bowel management systems market in the year 2023 and is expected to do the same during the forecast period. This is driven by the growing burden of Parkinson's disease, increasing regulatory approval, the presence of well-established healthcare infrastructure, and others, acting as key factors contributing to the growth of the bowel management systems market in the North America region during the forecast period from 2024 to 2030.

Parkinson's Foundation in 2024 stated that, currently near about one million people in the U.S. are living with Parkinson's disease. This number is projected to increase to 1.2 million by 2030. Parkinson's disease is the second-most common neurodegenerative disorder, following Alzheimer's disease. Each year, approximately 90,000 new cases of Parkinson's are diagnosed in the US.

Bowel management systems are essential for individuals with Parkinson's disease, as the condition frequently causes gastrointestinal issues like constipation and fecal incontinence. These systems assist in effective bowel irrigation and evacuation, helping patients maintain dignity and quality of life. As the disease progresses, tailored bowel management becomes critical, enabling patients and caregivers to address bowel dysfunction challenges. Integrating these systems into care plans supports better gastrointestinal health and overall well-being for those affected by Parkinson's disease.

Rising product developmental activities by regulatory bodies in the region will further boost the market for bowel management systems. For example, in February 2022, Medtronic received the USFDA approval for the InterStim X(TM) system, the next generation of the most personalized sacral nerve stimulation therapy for bladder and bowel control.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American bowel management systems market.

Bowel Management Systems Market key players:

Some of the key market players operating in the bowel management systems market include Coloplast Pty Ltd, Medtronic, ConvaTec Inc., Hollister Incorporated, B. Braun Melsungen AG, 3M, Cardinal Health., BD, Dentsply Sirona, Norgine, Attends Healthcare, Products, Inc., Teleflex Incorporated, Laborie, Consure Medical., Axonics, Inc., Renew Medical Inc, and others.

Recent Developmental Activities in the Bowel Management Systems Market:

  • In November 2021, Medtronic announced that the U.S. Food and Drug Administration, granted 510(k) clearance for its PillCam(TM) Small Bowel 3 system, intended for remote endoscopy procedures.
  • In October 2021, Laborie, acquired Pelvalon, Inc., a privately-held medical device company that developed an innovative product Eclipse(TM) System, a non-surgical, patient-controlled device for women suffering from faecal incontinence.
  • In May 2021, Axonics, Inc., a global medical technology company focused on developing and commercializing novel products for the treatment of bladder and bowel dysfunction, received European CE Mark approval for its second-generation Axonics r-SNM(R) implantable neurostimulator (INS) and wireless patient remote control with SmartMRI(TM) technology.

Key Takeaways from the Bowel Management Systems Market Report Study

  • Market size analysis for current bowel management systems market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the bowel management systems market.
  • Various opportunities available for the other competitors in the bowel management systems market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current bowel management systems market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for bowel management systems market growth in the coming future?

Target Audience who can be benefited from this Bowel Management Systems Market Report Study

  • Bowel management systems product providers
  • Research organizations and consulting companies
  • Bowel management systems-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in bowel management systems
  • Various end-users who want to know more about the bowel management systems market and the latest technological developments in the bowel management systems market

Frequently Asked Questions for the Bowel Management Systems Market:

1. What are Bowel Management Systems?

  • The bowel incontinence, also known as faecal incontinence is generally the situation when the patient is not able to control bowel movements which results in involuntary loss of solid or liquid stool. The clinical devices used to manage bowel activity are called bowel management systems.

2. What is the market for Bowel Management Systems?

  • The bowel management systems market was valued at USD 1.42 billion in 2023, growing at a CAGR of 3.98% during the forecast period from 2024 to 2030, to reach USD 1.78 billion by 2030.

3. What are the drivers for the Bowel Management Systems market?

  • The bowel management systems market is expanding rapidly due to the increasing prevalence of neurological disorders including multiple sclerosis, growing product developmental activities, increasing instances of spinal cord injuries, and others that are expected to escalate the overall growth of the bowel management systems market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Bowel Management Systems market?

  • Some of the key market players operating in bowel management systems include Coloplast Pty Ltd, Medtronic, ConvaTec Inc., Hollister Incorporated, B. Braun Melsungen AG, 3M, Cardinal Health., BD, Dentsply Sirona, Norgine, Attends Healthcare, Products, Inc., Teleflex Incorporated, Laborie, Consure Medical., Axonics, Inc., Renew Medical Inc, and others.

5. Which region has the highest share in the Bowel Management Systems market?

  • Among all the regions, North America is expected to dominate the bowel management systems market in the year 2023 and is expected to do the same during the forecast period. This is driven by the growing burden of Parkinson's disease, increasing regulatory approval, the presence of well-established healthcare infrastructure, and others, acting as key factors contributing to the growth of the bowel management systems market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Bowel Management Systems Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Bowel Management Systems Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Bowel Management Systems Market Key Factors Analysis

  • 5.1. Bowel Management Systems Market Drivers
    • 5.1.1. Increasing prevalence of neurological disorders
    • 5.1.2. Growing product developmental activities
    • 5.1.3. Increasing instances of spinal cord injury
    • 5.1.4. Rising aging population
  • 5.2. Bowel Management Systems Market Restraints and Challenges
    • 5.2.1. Side-effects such as infections, skin irritation, and bowel perforation, among others
    • 5.2.2. Availability of alternative options
  • 5.3. Bowel Management Systems Market Opportunities
    • 5.3.1. Development of more biocompatible materials

6. Bowel Management Systems Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Bowel Management Systems Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Devices
      • 7.1.1.1. Irrigation Systems
      • 7.1.1.2. Nerve Modulation Devices
      • 7.1.1.3. Others
    • 7.1.2. Accessories
  • 7.2. By Patient Type
    • 7.2.1. Adult
    • 7.2.2. Pediatrics
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centres
    • 7.3.3. Home Care
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.1.2. Canada Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.1.3. Mexico Bowel Management Systems Market Size in USD million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.2.2. Germany Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.2.4. Italy Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.2.5. Spain Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.2.6. Rest of Europe Bowel Management Systems Market Size in USD million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.3.2. Japan Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.3.3. India Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.3.4. Australia Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.3.5. South Korea Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Bowel Management Systems Market Size in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.4.2. Africa Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.4.3. South America Bowel Management Systems Market Size in USD million (2021-2030)

8. Bowel Management Systems Market Company and Product Profiles

  • 8.1. Coloplast Pty Ltd
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Medtronic
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. ConvaTec Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Hollister Incorporated
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. B. Braun Melsungen AG
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. 3M
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Cardinal Health.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. BD
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Dentsply Sirona
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Norgine
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Attends Healthcare Products, Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Teleflex Incorporated
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Laborie
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Consure Medical.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Axonics, Inc.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Renew Medical Inc
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Bowel Management Systems Market in Global (2021-2030)
  • Table 3: Bowel Management Systems Market in Global by Product Type (2021-2030)
  • Table 4: Bowel Management Systems Market in Global by Patient Type (2021-2030)
  • Table 5: Bowel Management Systems Market in Global by End-User (2021-2030)
  • Table 6: Bowel Management Systems Market in Global by Geography (2021-2030)
  • Table 7: Bowel Management Systems Market in North America (2021-2030)
  • Table 8: Bowel Management Systems Market in the United States (2021-2030)
  • Table 9: Bowel Management Systems Market in Canada (2021-2030)
  • Table 10: Bowel Management Systems Market in Mexico (2021-2030)
  • Table 11: Bowel Management Systems Market in Europe (2021-2030)
  • Table 12: Bowel Management Systems Market in France (2021-2030)
  • Table 13: Bowel Management Systems Market in Germany (2021-2030)
  • Table 14: Bowel Management Systems Market in United Kingdom (2021-2030)
  • Table 15: Bowel Management Systems Market in Italy (2021-2030)
  • Table 16: Bowel Management Systems Market in Spain (2021-2030)
  • Table 17: Bowel Management Systems Market in the Rest of Europe (2021-2030)
  • Table 18: Bowel Management Systems Market in Asia-Pacific (2021-2030)
  • Table 19: Bowel Management Systems Market in China (2021-2030)
  • Table 20: Bowel Management Systems Market in Japan (2021-2030)
  • Table 21: Bowel Management Systems Market in India (2021-2030)
  • Table 22: Bowel Management Systems Market in Australia (2021-2030)
  • Table 23: Bowel Management Systems Market in South Korea (2021-2030)
  • Table 24: Bowel Management Systems Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Bowel Management Systems Market in the Rest of the World (2021-2030)
  • Table 26: Bowel Management Systems Market in the Middle East (2021-2030)
  • Table 27: Bowel Management Systems Market in Africa (2021-2030)
  • Table 28: Bowel Management Systems Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Bowel Management Systems Market in Global (2021-2030)
  • Figure 3: Bowel Management Systems Market in Global by Product Type (2021-2030)
  • Figure 4: Bowel Management Systems Market in Global by Patient Type (2021-2030)
  • Figure 5: Bowel Management Systems Market in Global by End-User (2021-2030)
  • Figure 6: Bowel Management Systems Market in Global by Geography (2021-2030)
  • Figure 7: Bowel Management Systems Market in North America (2021-2030)
  • Figure 8: Bowel Management Systems Market in the United States (2021-2030)
  • Figure 9: Bowel Management Systems Market in Canada (2021-2030)
  • Figure 10: Bowel Management Systems Market in Mexico (2021-2030)
  • Figure 11: Bowel Management Systems Market in Europe (2021-2030)
  • Figure 12: Bowel Management Systems Market in France (2021-2030)
  • Figure 13: Bowel Management Systems Market in Germany (2021-2030)
  • Figure 14: Bowel Management Systems Market in United Kingdom (2021-2030)
  • Figure 15: Bowel Management Systems Market in Italy (2021-2030)
  • Figure 16: Bowel Management Systems Market in Spain (2021-2030)
  • Figure 17: Bowel Management Systems Market in the Rest of Europe (2021-2030)
  • Figure 18: Bowel Management Systems Market in Asia-Pacific (2021-2030)
  • Figure 19: Bowel Management Systems Market in China (2021-2030)
  • Figure 20: Bowel Management Systems Market in Japan (2021-2030)
  • Figure 21: Bowel Management Systems Market in India (2021-2030)
  • Figure 22: Bowel Management Systems Market in Australia (2021-2030)
  • Figure 23: Bowel Management Systems Market in South Korea (2021-2030)
  • Figure 24: Bowel Management Systems Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Bowel Management Systems Market in the Rest of the World (2021-2030)
  • Figure 26: Bowel Management Systems Market in the Middle East (2021-2030)
  • Figure 27: Bowel Management Systems Market in Africa (2021-2030)
  • Figure 28: Bowel Management Systems Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis